arrow
C

Chukiat Sirivichayakul

Mahidol University
H指数:29
被引数:3,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program

疫苗病毒血症、减毒株回复和安全性表征:TAK-003登革热疫苗临床开发项目的综合结果

Vaccine
IF3.5
2026-07-012
OAAI
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)
2021-10-04143
OAAI
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines
2021-07-0112
OAAI
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
2020-12-1565
OAAI
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents
2019-11-21237
OAAI
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial
2018-11-0126
PREAI
Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

灭活色谱纯化的Vero细胞衍生的日本脑炎疫苗在泰国儿童中的免疫原性和安全性

2018-01-1616
OAAI
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
2018-01-0126
PREAI